High-intensity Small-sided Soccer Games for Cardiometabolic Health in Adolescents With Metabolic Dysfunction

April 17, 2024 updated by: Hélder Fonseca, Universidade do Porto

High Intensity Training Based on Small-sided Soccer Games for Health: Effects on Cardiometabolic Health, Motor Performance and Adherence to 24-hour Movement Guidelines in Adolescents With Overweight and Metabolic Dysfunction

Pediatric obesity is considered one of the most important public health problems worldwide due to its high prevalence and associated comorbidities. Physical exercise has been shown to have an important role in the treatment of obesity and associated cardiometabolic dysfunction. Small-sided soccer games (SSSG) have been explored as a promising way of increasing physical exercise due to its benefits on cardiometabolic health and high degree of enjoyment, which favors long-term adherence.

The objective of this research is to determine the effects of a 16-week high-intensity SSSG-based exercise intervention on cardiometabolic risk factors, physical fitness, adherence to 24-hour movement patterns, enjoyment and adherence to the intervention in adolescents with metabolic dysfunction and compare them to the effects of a traditional soccer intervention.

The investigators hypothesize that high-intensity SSSG are more effective in improving the obesity-related cardiometabolic risk profile in adolescents with cardiometabolic dysfunction compared to traditional soccer training.

A parallel 3-arm randomized controlled trial will be conducted in adolescents with overweight and metabolic dysfunction between 11 and 15 years of age. The inclusion criteria are: (i) age between 11-15 years at the time of intervention start; (ii) overweight or obesity (BMI> 85th percentile); (iii) Abdominal obesity ≥90th percentile as assessed by waist circumference or a waist-to-height ratio ≥ 0.5; (iv) willing to participate in the study regardless of possible group allocation; (v) informed consent given by participant and legal representatives. Exclusion criteria: (i) health condition not compatible with participation in physical exercise; (ii) history of recent musculoskeletal injury hindering exercise participation; (iii) concurrent participation in a structured weight loss or exercise program.

Those eligible to participate in the study will be randomly assigned to one of three groups: i) SSSG group, ii) traditional soccer play group (TSG), or, iii) non-exercise intervention control group (CG). Participants in both exercise intervention groups will undergo a 16-week intervention. The SSSG group will participate in a high-intensity small-sided soccer games training, while the TSG will undergo a technical and tactical skills training program and traditional soccer training. The CG participants will continue with regular school physical education classes without any additional intervention. Before and after the intervention, all participants will be assessed for cardiometabolic and hepatic biochemical markers, physical fitness, anthropometry and body composition, blood pressure, objective daily physical activity and sleep quality, and perceived enjoyment of participation in SSSG and TSG. The primary outcomes of the study will be waist circumference and cardiorespiratory fitness.

The study protocol was approved by the Ethics Committee of the Faculty of Sport of the University of Porto and by the Scientific Ethics Committee of the Adventist University of Chile.

Study Overview

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Porto, Portugal, 4200-450
        • Faculty of Sport of the University of Porto

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 11-15 years at the time of intervention start
  • Overweight or obesity (BMI> 85th percentile)
  • Abdominal obesity ≥90th percentile as assessed by waist circumference or a waist-to- height ratio ≥ 0.5
  • Willing to participate in the study regardless of possible group allocation
  • Informed consent given by participant and legal representatives

Exclusion Criteria:

  • Health condition not compatible with participation in physical exercise
  • History of recent musculoskeletal injury hindering exercise participation
  • Concurrent participation in a structured weight loss or exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Small-sided soccer games groups (SSSG)

SSSG will perform 16 weeks of training, 3 sessions/week, and ~55 minutes/session. Each session will begin with a 15-minute warm-up, 32 minutes of principal activity, and 5 minutes of cool down. The SSSG will consist of a program based on high-intensity SSSG.

The training protocol is based on a pilot study conducted to characterize the exertion profile. The SSSG will be performed in a fractional regimen of 8 sets of 4 minutes and 2 minutes rest. The format of the SSGs will be 3v3, although they can be adapted to 2v2 or 4v4 when necessary. In addition, it will take place in a playing area of 9 x 18 meters equivalent to 27 square meters per player. To encourage high intensity, the following will be used (i) man-to-man marking; (ii) to score a goal, the entire team must be in the opponent's half of the field; (iii) balls will be available to reduce stoppages in play; (iv) the coach will motivate the team to maintain high intensity.

Physical exercise intervention
Experimental: Traditional soccer training groups (TSG)

SSSG will perform 16 weeks of training, 3 sessions/week, and ~55 minutes/session. Each session will begin with a 15-minute warm-up, 32 minutes of principal activity, and 5 minutes of cool down.

The TSG group will base its training on 30 minutes of technical exercises with the ball individually or in pairs (dribbling, shooting and passing), ending with 10 minutes of a match organized according to the original characteristics of an indoor soccer game.

Physical exercise intervention
No Intervention: Control Group (CG)
CG will perform only regular school physical education classes without any additional intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Waist circumference
Time Frame: 16 weeks
Anthropometric measurement of abdominal obesity; cm
16 weeks
Cardiorespiratory fitness
Time Frame: 16 weeks
1-mile walk/run test; minutes to run 1 mile
16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation in fasting blood glucose concentration (mg/dL)
Time Frame: 16 weeks

Variation in fasting blood glucose concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in serum insulin concentration (mU/L)
Time Frame: 16 weeks

Variation in serum insulin concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in HOMA-IR
Time Frame: 16 weeks

Variation in HOMA-IR after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in glycosylated hemoglobin concentration (mg/dL)
Time Frame: 16 weeks

Variation in Glycosylated hemoglobin concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in high-density lipoprotein cholesterol concentration (mg/dL)
Time Frame: 16 weeks

Variation in High-density lipoprotein cholesterol concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in low-density lipoprotein cholesterol concentration (mg/dL)
Time Frame: 16 weeks

Variation in low-density lipoprotein cholesterol concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in total cholesterol concentration (mg/dL)
Time Frame: 16 weeks

Variation in total cholesterol concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in blood triglycerides concentration (mg/dL)
Time Frame: 16 weeks

Variation in blood triglycerides concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in blood Alanine aminotransferase concentration (U/L)
Time Frame: 16 weeks

Variation in blood Alanine aminotransferase concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in blood Aspartate aminotransferase concentration (U/L)
Time Frame: 16 weeks

Variation in blood Aspartate aminotransferase concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
Variation in blood Gamma glutamyl transferase concentration (U/L)
Time Frame: 16 weeks

Variation in blood Gamma glutamyl transferase concentration after 16 weeks of intervention.

Blood samples will be obtained from each subject early in the morning by venipuncture from the antecubital vein, following a 10-h overnight fast.

16 weeks
6-minute walk test
Time Frame: 16 weeks
Distance covered walking in 6 minutes.
16 weeks
Hand grip strength
Time Frame: 16 weeks
Hand grip strength test measured with a digital hand dynamometer
16 weeks
Lower limb strength
Time Frame: 16 weeks
Assessed by Horizontal jump test.
16 weeks
Body composition
Time Frame: 16 weeks
Assessed by the electrical bioimpedance method
16 weeks
Body mass index
Time Frame: 16 weeks
Weight and height will be combined to report BMI in kg/m^2
16 weeks
Neck circumference
Time Frame: 16 weeks
Assessed by anthropometric techniques
16 weeks
Blood Pressure (mmHg)
Time Frame: 16 weeks
Systolic and diastolic blood pressure measured with digital sphygmomanometer
16 weeks
Physical activity
Time Frame: 16 weeks
Physical activity will be assessed objectively with a triaxial accelerometer used 24h/d during 7 consecutive days.
16 weeks
Sleep quality
Time Frame: 16 weeks
Sleep quality will be assessed objectively with a triaxial accelerometer used 24h/d during 7 consecutive days.
16 weeks
Perceived enjoyment of physical activity
Time Frame: 16 weeks
Assessed by the Physical Activity Enjoyment Scale questionnaire (PACES). Raw scores are transformed into a scale from 16 to 80. Higher scores correspond to higher perceived enjoyment.
16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2023

Primary Completion (Actual)

April 10, 2023

Study Completion (Actual)

September 1, 2023

Study Registration Dates

First Submitted

April 1, 2024

First Submitted That Met QC Criteria

April 17, 2024

First Posted (Actual)

April 22, 2024

Study Record Updates

Last Update Posted (Actual)

April 22, 2024

Last Update Submitted That Met QC Criteria

April 17, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on Small-sided soccer games groups (SSSG)

Subscribe